Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) PAR-19-287 NCI The National Cancer Institutes (NCI) Cancer Systems Biology Consortium (CSBC) supports systems biology approaches to cancer research and includes U54 CSBC Research Centers, a U24 CSBC Coordinating… More
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 NCI The National Cancer Institutes (NCI) Cancer Systems Biology Consortium (CSBC, https://csbconsortium.org/) supports the application of systems biology approaches to cancer research and includes U01… More
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) PAR-19-389 NCI The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and… More
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) PAR-21-111 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) RFA-CA-21-010 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U2C Resource-Related Multi… More
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) PAR-20-314 NCI The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers… More
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) PAR-19-199 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses.… More
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) PA-19-112 NCI This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-… More
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) PAR-21-330 NCI This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of… More
National Cancer Institute (NCI) Request for Information (RFI): Strategies for Matching Patients to Clinical Trials NOT-CA-18-063 NCI N/A National Cancer Institute NCI) Request Information RFI): Strategies Matching Patients Clinical Trials Notice Number: NOT-CA-18-063 Key Dates Release Date: April 11, 2018 Related Announcements None… More
Updated: